Ligand validation:2AGD

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2AGD_MES_C_439	1%	45%	0.368	0.517	1.49	0.7	3	-	2	0	100%	1
2AES_MES_C_436	3%	44%	0.313	0.671	1.52	0.72	3	-	1	0	100%	1
3EE5_MES_C_436	2%	46%	0.307	0.547	1.32	0.79	2	-	2	0	100%	1
2AH9_MES_C_433	1%	35%	0.324	0.529	1.81	0.86	4	-	6	0	100%	1
2AEC_MES_C_436	1%	46%	0.36	0.434	1.47	0.67	3	-	3	0	100%	1
8AJQ_MES_H_201	100%	39%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
4NWT_MES_L_301	100%	25%	0.045	0.99	1.24	1.94	2	4	0	0	100%	1
4S23_MES_B_502	100%	24%	0.05	0.993	1.97	1.34	1	1	0	0	100%	1
5NJ9_MES_A_502	99%	61%	0.049	0.988	0.71	0.74	-	1	0	0	100%	1
4BRG_MES_B_1399	99%	13%	0.061	0.988	1.72	2.42	3	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.